Biotech Values

[DragonBits]

jbog, but whatever they might have done with the over-allotment, keep the shares on their own books or sell them on the open market, it would have to be reported the same. Even if they needed to cover a short position it would still have to take shares and report them. The money (14.35) would have still gone to MNTA

The only logical explanation is that they didn't want to keep the shares and selling them would have caused the stock to decline more than the 14.35 selling price creating a loss and / or displeasure from those they sold the stock to. It would seem to indicate MNTA is weaker than I would have thought.

From what I read on this board I don't really get it, it would seem MNTA should be good buy at 14.35, but this seems to indicate otherwise.

Can you reach any other conclusion?